These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6858768)

  • 1. Methods for evaluating treatment in Parkinson's disease.
    Ward CD; Sanes JN; Dambrosia JM; Calne DB
    Adv Neurol; 1983; 37():1-7. PubMed ID: 6858768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of disability in Parkinson's disease. Clinical evaluation and instrumental tests.
    Junqué C; Peirò A; Tordesillas C; Grau-Veciana JM
    Funct Neurol; 1987; 2(3):293-300. PubMed ID: 3692273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease.
    Midi I; Dogan M; Koseoglu M; Can G; Sehitoglu MA; Gunal DI
    Acta Neurol Scand; 2008 Jan; 117(1):26-34. PubMed ID: 18031561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.
    Lemay S; Chouinard S; Blanchet P; Masson H; Soland V; Beuter A; Bédard MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):31-9. PubMed ID: 14687854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
    O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
    Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of motor symptoms upon the quality of life of patients with Parkinson's disease.
    Gómez-Esteban JC; Zarranz JJ; Lezcano E; Tijero B; Luna A; Velasco F; Rouco I; Garamendi I
    Eur Neurol; 2007; 57(3):161-5. PubMed ID: 17213723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors associated with the development of motor complications in Parkinson's disease. A study in a Chilean population].
    Juri-Claveria C; Aguirre-M C; Viviani-G P; Chana-Cuevas P
    Rev Neurol; 2007 Jul 16-31; 45(2):77-80. PubMed ID: 17642046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.
    Stacy M; Bowron A; Guttman M; Hauser R; Hughes K; Larsen JP; LeWitt P; Oertel W; Quinn N; Sethi K; Stocchi F
    Mov Disord; 2005 Jun; 20(6):726-33. PubMed ID: 15719426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
    Doan JB; Melvin KG; Whishaw IQ; Suchowersky O
    Behav Brain Res; 2008 Dec; 194(2):207-13. PubMed ID: 18692094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The usefulness of timed motor tests in assessing Parkinson's disease].
    García-Ruiz PJ; Sánchez-Bernardos V; Cabo-López I
    Rev Neurol; 2009 Jun 16-30; 48(12):617-9. PubMed ID: 19507119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease.
    De Reuck J; De Weweire M; Van Maele G; Santens P
    J Neurol Sci; 2005 Apr; 231(1-2):35-9. PubMed ID: 15792818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease.
    Lemke MR; Brecht HM; Koester J; Reichmann H
    J Neurol Sci; 2006 Oct; 248(1-2):266-70. PubMed ID: 16814808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
    Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
    Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic comparison of ropinirole 24-hour prolonged release and ropinirole immediate release in patients with Parkinson's disease.
    Tompson D; Oliver-Willwong R
    Clin Neuropharmacol; 2009; 32(3):140-8. PubMed ID: 18978485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: a pharmacokinetic/pharmacodynamic, randomized, double-blind study.
    Simon N; Micallef J; Reynier JC; Lesourd M; Witjas T; Alicherif A; Azulay JP; Blin O
    Mov Disord; 2005 Jul; 20(7):803-9. PubMed ID: 15726579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
    Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
    Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Mobility Task: index for evaluating motor impairment and motor rehabilitation programs in Parkinson's disease patients.
    Peppe A; Ranaldi A; Chiavalon C; Gasbarra A; Collepardo A; Romeo R; Pasqualetti P; Caltagirone C
    Acta Neurol Scand; 2007 Sep; 116(3):182-9. PubMed ID: 17714332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of clinical progression in Parkinson's disease. A prospective study.
    Schrag A; Dodel R; Spottke A; Bornschein B; Siebert U; Quinn NP
    Mov Disord; 2007 May; 22(7):938-45. PubMed ID: 17415791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.